Application of Plantibodies, the Plant-MADE Vaccines

• Published in: International Journal of Environment and Climate Change pp. 171 - 180
• Main Authors: R., Arthee, Rangasami, S. R., Murugaragavan, ., Prabu, P. C., Ramesh, P. T., Chelladurai, K., Rakesh, S. S., Pandiyarajan, P.
• Format: Journal Article
• Language: English
• Published: 02.05.2022
• ISSN: 2581-8627; 2581-8627
• DOI: 10.9734/ijecc/2022/v12i1030783

Various approaches are used to integrate the desired genes encoding the antigen protein for a given illness into the genome of plant tissues in plant-based vaccination technology. Gene transfer by agrobacterium and transformation via a genetically engineered plant virus are two typical approaches for producing efficient vaccinations. Antibodies are an important component of vertebrates' adaptive immune systems, and they may now be made by converting plants with antibody-coding genes from animals and humans. Despite the fact that plants do not produce antibodies naturally, plant-derived antibodies (plantibodies) have been proven to behave similarly to mammalian antibodies. However, as science and technology have progressed, new approaches have been created to improve the efficiency of older technologies including biolistic, electroporation, agroinfiltration, sonication, and polyethylene glycol treatment. Despite the fact that plant-based vaccinations have numerous advantages for the vaccine industry, there are still constraints that limit the rate at which these third-generation vaccines may be successfully manufactured. Despite these limitations, continued attempts are still underway to develop effective vaccines for a variety of human and animal diseases, owing to its enormous potential.